Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression
Najla Arshad, Maudry Laurent-Rolle, Wesam S. Ahmed, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Amy D. Proal, Michael B. VanElzakker, Soo Aleman, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1616-1627
Open Access | Times Cited: 171
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 94
A membrane-associated MHC-I inhibitory axis for cancer immune evasion
Xufeng Chen, Lu Qiao, Hua Zhou, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3903-3920.e21
Closed Access | Times Cited: 78
SARS-CoV-2 biology and host interactions
Silvio Steiner, Annika Kratzel, G. Tuba Barut, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 4, pp. 206-225
Closed Access | Times Cited: 74
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1711-1724
Open Access | Times Cited: 69
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection
Fei Gao, Vamsee Mallajosyula, Prabhu S. Arunachalam, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 864-878.e4
Open Access | Times Cited: 58
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells
Nicolas Huot, Cyril Planchais, Pierre Rosenbaum, et al.
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 2068-2079
Open Access | Times Cited: 43
Defining the role of natural killer cells in COVID-19
Madeline Lee, Catherine A. Blish
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1628-1638
Open Access | Times Cited: 34
Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants
Miyu Moriyama, Carolina Lucas, Valter Silva Monteiro, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 16
Open Access | Times Cited: 28
COVID-19 annual update: a narrative review
Michela Biancolella, Vito Luigi Colona, Lucio Luzzatto, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 28
SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19
Ariana Arduini, Frederique Laprise, Chen Liang
Viruses (2023) Vol. 15, Iss. 4, pp. 871-871
Open Access | Times Cited: 22
Targeting MHC-I inhibitory pathways for cancer immunotherapy
Jun Wang, Lu Qiao, Xufeng Chen, et al.
Trends in Immunology (2024) Vol. 45, Iss. 3, pp. 177-187
Closed Access | Times Cited: 11
Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
Jordan A. Hartmann, Marcella R. Cardoso, Maria Cecília Ramiro Talarico, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2393-2410.e14
Closed Access | Times Cited: 9
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions
Smita Vinjamuri, Lenong Li, Marlène Bouvier
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D
Madeline Lee, Michelle Leong, Arjun Rustagi, et al.
Cell Reports (2022) Vol. 41, Iss. 13, pp. 111892-111892
Open Access | Times Cited: 34
Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expression
Vitor R. C. Aguiar, Erick C. Castelli, Richard M. Single, et al.
Immunogenetics (2023) Vol. 75, Iss. 3, pp. 249-262
Open Access | Times Cited: 20
Long-read direct RNA sequencing reveals epigenetic regulation of chimeric gene-transposon transcripts in Arabidopsis thaliana
Jérémy Berthelier, Leonardo Furci, Shuta Asai, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Coronavirus accessory protein ORF3 biology and its contribution to viral behavior and pathogenesis
Fusheng Si, Shuai Song, Ruisong Yu, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106280-106280
Open Access | Times Cited: 17
Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release
Hazel Stewart, Roberta Palmulli, K. Johansen, et al.
EMBO Reports (2023) Vol. 24, Iss. 12
Open Access | Times Cited: 16
Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2
Brian C. Ware, M. Guston Parks, Mariana Oliveira Lopes da Silva, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1011794-e1011794
Open Access | Times Cited: 6
Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation
Jamina Brunnberg, Martina Barends, Stefan Frühschulz, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 22
Open Access | Times Cited: 5
Virus-specific T cell response in SARS-CoV-2 infection and vaccinations
Antonio Bertoletti, Martin Qui, Joey Ming Er Lim
Elsevier eBooks (2025), pp. 191-206
Closed Access
Navigating the Unknown: Open Questions Surrounding Natural Killer Cell Responses to SARS-CoV-2
Quirin Hammer
Springer eBooks (2025), pp. 1-21
Closed Access
Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective multicenter study
Kuganya Nirmalarajah, Patryk Aftanas, Shiva Barati, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top